CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Starpharma Holdings Limited - ADR Company Snapshot
Starpharma Holdings Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Starpharma Holdings Limited with three other companies in this sector in UNITED STATES : Applied Genetic Technologies Corp (2020 sales of $2.45 million of which 100% was Gene therapy), Pharmaxis Ltd ($8.41 million of which 56% was Mannitol), and Bioxyne Limited ($1.51 million ).

Sales Analysis. During the year ended June of 2020, sales at Starpharma Holdings Limited were $4.77 million. This is an increase of 145.3% versus 2019, when the company's sales were $1.94 million.
   
   
 
  Stock Performance Chart for Starpharma Holdings Limited - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 12.27
(Figures in U.S. Dollars)
1 Week 4.9%   13 Weeks 62.7%  
4 Weeks 62.7%   52 Weeks 54.5%  
 
Starpharma Holdings Limited - ADR Key Data:
  Ticker: SPHRY Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 4,768,971
(Year Ending Jan 2021).
Employees: 49
  Currency: U.S. Dollars Market Cap: 456,948,136
  Fiscal Yr Ends: June Shares Outstanding: 37,256,269
  Share Type: Common Closely Held Shares: 3,793,533
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.